Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Felsenstein

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 10, 2008
Cathepsins B and L differentially regulate amyloid precursor protein processingDonna M Klein, Kevin M Felsenstein, Douglas E Brenneman
Translational Research : the Journal of Laboratory and Clinical Medicine|November 30, 2013
Regenerative medicine in Alzheimer's diseaseKevin M Felsenstein, Kate M Candelario, Dennis A Steindler, et al.
Current Pharmaceutical Design|February 7, 2003
Emerging beta-amyloid therapies for the treatment of Alzheimer's diseaseKelly A Conway, Ellen W Baxter, Kevin M Felsenstein, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Inhibitors of Abeta production: solid-phase synthesis and SAR of alpha-hydroxycarbonyl derivativesOwen B Wallace, David W Smith, Milind S Deshpande, et al.
Biochimica Et Biophysica Acta|June 25, 2013
γ-Secretase inhibitors and modulatorsTodd E Golde, Edward H Koo, Kevin M Felsenstein, et al.
Current Alzheimer Research|July 14, 2007
A comparative analysis of brain and plasma Abeta levels in eight common non-transgenic mouse strains: validation of a specific immunoassay for total rodent AbetaGeorge J Yohrling, Kevin M Felsenstein, Kelly A Conway, et al.
Plos One|June 6, 2015
Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase InhibitorsYong Ran, Gabriela Z Ladd, Carolina Ceballos-Diaz, et al.
Science (New York, N.Y.)|May 25, 2013
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"Ashleigh R Price, Guilian Xu, Zoe B Siemienski, et al.
The Journal of Biological Chemistry|December 20, 2013
γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cellsYong Ran, Pedro E Cruz, Thomas B Ladd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 30, 2013
Steroids as γ-secretase modulatorsJoo In Jung, Thomas B Ladd, Thomas Kukar, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|December 10, 2008
Cathepsins B and L differentially regulate amyloid precursor protein processingDonna M Klein, Kevin M Felsenstein, Douglas E Brenneman
Translational Research : the Journal of Laboratory and Clinical Medicine|November 30, 2013
Regenerative medicine in Alzheimer's diseaseKevin M Felsenstein, Kate M Candelario, Dennis A Steindler, et al.
Current Pharmaceutical Design|February 7, 2003
Emerging beta-amyloid therapies for the treatment of Alzheimer's diseaseKelly A Conway, Ellen W Baxter, Kevin M Felsenstein, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Inhibitors of Abeta production: solid-phase synthesis and SAR of alpha-hydroxycarbonyl derivativesOwen B Wallace, David W Smith, Milind S Deshpande, et al.
Biochimica Et Biophysica Acta|June 25, 2013
γ-Secretase inhibitors and modulatorsTodd E Golde, Edward H Koo, Kevin M Felsenstein, et al.
Current Alzheimer Research|July 14, 2007
A comparative analysis of brain and plasma Abeta levels in eight common non-transgenic mouse strains: validation of a specific immunoassay for total rodent AbetaGeorge J Yohrling, Kevin M Felsenstein, Kelly A Conway, et al.
Plos One|June 6, 2015
Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase InhibitorsYong Ran, Gabriela Z Ladd, Carolina Ceballos-Diaz, et al.
Science (New York, N.Y.)|May 25, 2013
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"Ashleigh R Price, Guilian Xu, Zoe B Siemienski, et al.
The Journal of Biological Chemistry|December 20, 2013
γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cellsYong Ran, Pedro E Cruz, Thomas B Ladd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 30, 2013
Steroids as γ-secretase modulatorsJoo In Jung, Thomas B Ladd, Thomas Kukar, et al.
Pageof 3